Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Authors: Chi Zhang, Zhao Wu, Jiawen Li, Hong Zhao, Gui-Qiang Wang

Year: 2020

TocilizumabCytokine stormCytokine release syndromeMedicinePneumonia